Quality metrics in the management of acute stroke in Greece during the first 5 years of Registry of Stroke Care Quality (RES-Q) implementation.
Greece
Stroke
acute reperfusion treatment
functional outcome
quality
registry
Journal
European stroke journal
ISSN: 2396-9881
Titre abrégé: Eur Stroke J
Pays: England
ID NLM: 101688446
Informations de publication
Date de publication:
01 2023
01 2023
Historique:
received:
13
03
2022
accepted:
09
05
2022
entrez:
16
2
2023
pubmed:
17
2
2023
medline:
17
2
2023
Statut:
ppublish
Résumé
Establishment of a prospective stroke registry may promote the documentation and improvement of acute stroke care. We present the status of stroke management in Greece using the Registry of Stroke Care Quality (RES-Q) dataset. Consecutive patients with acute stroke were prospectively registered in RES-Q registry by contributing sites in Greece during the years 2017-2021. Demographic and baseline characteristics, acute management, and clinical outcomes at discharge were recorded. Stroke quality metrics, with a specific interest in the association between acute reperfusion therapies and functional recovery in ischemic stroke patients are presented. A total of 3590 acute stroke patients were treated in 20 Greek sites (61% men, median age 64 years; median baseline NIHSS 4; 74% ischemic stroke). Acute reperfusion therapies were administered in almost 20% of acute ischemic stroke patients, with a door to needle and door to groin puncture times of 40 and 64 min, respectively. After adjustment for contributing sites, the rates of acute reperfusion therapies were higher during the time epoch 2020-2021 compared to 2017-2019 (adjusted OR 1.31; 95% CI 1.04-1.64; Implementation and maintenance of a nationwide stroke registry in Greece may guide the stroke management planning, so that prompt patient transportation, acute reperfusion therapies, and stroke unit hospitalization become more widely accessible, improving the functional outcomes of stroke patients.
Identifiants
pubmed: 36793743
doi: 10.1177/23969873221103474
pii: 10.1177_23969873221103474
pmc: PMC9923128
doi:
Types de publication
Journal Article
Langues
eng
Pagination
5-15Informations de copyright
© European Stroke Organisation 2022.
Déclaration de conflit d'intérêts
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Références
Eur Stroke J. 2020 Jun;5(2):204-212
pubmed: 32637654
Eur Stroke J. 2021 Mar;6(1):I-LXII
pubmed: 33817340
Ther Adv Neurol Disord. 2021 Feb 26;14:1756286421997368
pubmed: 33737956
Qual Saf Health Care. 2008 Oct;17(5):329-33
pubmed: 18842970
Stroke. 2015 Jul;46(7):2032-60
pubmed: 26022637
BMJ Open. 2018 Nov 12;8(11):e022536
pubmed: 30420348
Pharmacoecon Open. 2017 Jun;1(2):117-121
pubmed: 29442333
Neurology. 2016 May 31;86(22):2042-8
pubmed: 27164692
Eur Stroke J. 2019 Jun;4(2):101-109
pubmed: 31259258
Stroke. 2020 Nov;51(11):3310-3319
pubmed: 33023425
Stroke. 2019 Jun;50(6):1525-1530
pubmed: 31084337
Curr Atheroscler Rep. 2017 Nov 7;19(12):59
pubmed: 29116473
J Clin Invest. 2020 Jun 1;130(6):2745-2748
pubmed: 32243259
Stroke. 2007 Mar;38(3):1091-6
pubmed: 17272767
Stroke. 2020 Nov;51(11):3241-3249
pubmed: 33081604
J Neurol. 2017 May;264(5):912-920
pubmed: 28315960
Eur J Neurol. 2021 Oct;28(10):3452-3455
pubmed: 33290619
Stroke. 2018 Oct;49(10):2398-2405
pubmed: 30355094
BMC Neurol. 2006 Jun 01;6:20
pubmed: 16740167
Eur J Neurol. 2020 Jun;27(6):1039-1047
pubmed: 32149450
Stroke. 2018 Feb;49(2):288-295
pubmed: 29335330
Ther Adv Neurol Disord. 2020 Dec 8;13:1756286420978004
pubmed: 33343709
Clin Epidemiol. 2013 Dec 23;6:27-36
pubmed: 24399886
Fam Med Community Health. 2020 Aug;8(3):
pubmed: 32816942
Int J Health Geogr. 2018 Jan 12;17(1):1
pubmed: 29329535
Stroke. 2018 Oct;49(10):2391-2397
pubmed: 30355086
Age Ageing. 2020 Feb 27;49(2):277-282
pubmed: 31957781
Eur Stroke J. 2021 Jun;6(2):151-159
pubmed: 34414290
Eur Stroke J. 2018 Dec;3(4):361-368
pubmed: 31236484
BMJ Open. 2021 Dec 6;11(12):e049086
pubmed: 34872995
Health Policy. 2021 Apr;125(4):520-525
pubmed: 33558022
Ther Adv Neurol Disord. 2021 Jul 07;14:17562864211029540
pubmed: 34285718
Eur Stroke J. 2021 Jun;6(2):CLXIII-CLXXXVI
pubmed: 34414299
Int J Stroke. 2014 Oct;9(7):840-55
pubmed: 25156220
Multivariate Behav Res. 2011 May;46(3):399-424
pubmed: 21818162
Stroke. 2021 Aug;52(9):3054-3062
pubmed: 34320814
Ther Adv Neurol Disord. 2021 Sep 22;14:17562864211045876
pubmed: 34589140
Ther Adv Neurol Disord. 2018 Jun 28;11:1756286418783578
pubmed: 30034535
BMC Med Res Methodol. 2013 Oct 28;13:132
pubmed: 24164771
J Neurointerv Surg. 2022 Mar;14(3):209
pubmed: 35115395
Expert Opin Investig Drugs. 2021 Oct;30(10):1025-1035
pubmed: 34555978
Diabetes. 2019 Sep;68(9):1861-1869
pubmed: 31217175
JAMA Neurol. 2020 Jan 1;77(1):16-24
pubmed: 31545353
PLoS One. 2021 Dec 10;16(12):e0261319
pubmed: 34890436
Cochrane Database Syst Rev. 2020 Apr 23;4:CD000197
pubmed: 32324916
Ann Neurol. 2018 Jul;84(1):89-97
pubmed: 30048012
Int J Stroke. 2016 Jan;11(1):28-40
pubmed: 26763018
Age Ageing. 2002 Sep;31(5):365-71
pubmed: 12242199
J Stroke. 2020 Jan;22(1):130-140
pubmed: 32027798
J Neurol. 2018 Oct;265(10):2379-2387
pubmed: 30128708
Front Neurol. 2021 Sep 07;12:723637
pubmed: 34557152
Folia Med (Plovdiv). 2003;45(4):5-10
pubmed: 15272808
Lancet Neurol. 2021 Oct;20(10):795-820
pubmed: 34487721
Stroke. 2019 Dec;50(12):e344-e418
pubmed: 31662037
Ann Neurol. 2021 Feb;89(2):380-388
pubmed: 33219563
Eur Stroke J. 2019 Mar;4(1):6-12
pubmed: 31165090
Stroke. 2013 Dec;44(12):3382-93
pubmed: 24222046